Keyhole Limpet Hemocyanin
Showing 1 - 25 of 138
Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)
Recruiting
- Immune Response
- Keyhole-Limpet Hemocyanin
- +3 more
-
Oxford, United KingdomNIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023
HIV Trial in Boston, New York (ALVAC(2)120(B,MN)GNP (vCP1452), Keyhole-Limpet Hemocyanin)
Completed
- HIV Infections
- ALVAC(2)120(B,MN)GNP (vCP1452)
- Keyhole-Limpet Hemocyanin
-
Boston, Massachusetts
- +1 more
Oct 28, 2021
Breast Cancer Trial in New York (QS21, sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine, immunoenzyme technique)
Completed
- Breast Cancer
- QS21
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 16, 2020
Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab, Tetanus toxoid (TT) containing vaccine (Td, Tdap), 13-valent
Recruiting
- Relapsing Multiple Sclerosis
- Ofatumumab
- +5 more
-
Birmingham, Alabama
- +295 more
Jan 13, 2023
Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)
Withdrawn
- Glioblastoma
- Glioma
- Bevacizumab
- +3 more
-
New York, New YorkNYU Perlmutter Cancer Center
Jan 8, 2020
Healthy Volunteer Trial in Leeds (Fimaporfin (Photosensitizer), Hiltonol (Poly-ICLC), HPV E7 (Human Papilloma Virus E7)
Completed
- Healthy Volunteer
- Fimaporfin (Photosensitizer)
- +3 more
-
Leeds, United KingdomCovance Clinical Research Unit Limited
Aug 22, 2019
KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers Trial in Leiden (EDP1815, EDP2939, Placebo oral capsule)
Recruiting
- KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers
- EDP1815
- +2 more
-
Leiden, NetherlandsCentre for Human Drug Research
Jan 11, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)
Recruiting
- Metastatic Pancreatic Cancer
- MesoPher
- Mitazalimab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Dec 6, 2022
Healthy Volunteers Trial in Hakata (ONO-4685, Placebo, KLH)
Completed
- Healthy Volunteers
- ONO-4685
- +4 more
-
Hakata, Fukuoka, JapanFukuoka Clinical Site
Nov 9, 2021
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin
Completed
- Refractory Multiple Myeloma
- +3 more
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 2, 2019
Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- 23-PPV
- +5 more
-
Cullman, Alabama
- +21 more
Apr 4, 2022
Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)
Recruiting
- Newly Diagnosed Glioblastoma
- SurVaxM
-
San Francisco, California
- +9 more
Aug 23, 2022
Lymphoma Trial in Omaha (autologous tumor cell vaccine, keyhole limpet hemocyanin, sargramostim)
Terminated
- Lymphoma
- autologous tumor cell vaccine
- +3 more
-
Omaha, NebraskaUNMC Eppley Cancer Center at the University of Nebraska Medical
Aug 2, 2018
Prostatic Tumors, Immunotherapy, Dendritic Cells Trial in Nijmegen (mDC vaccination, pDC vaccination, mDC and pDC vaccination)
Completed
- Prostatic Neoplasms
- +3 more
- mDC vaccination
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University Nijmegen Medical Centre
Nov 13, 2019
Sugarbaker and Keyhole Repair for Parastomal Hernia
Not yet recruiting
- Parastomal Hernia
- Keyhole repair
- Sugarbaker repair
- (no location specified)
Oct 8, 2023
Myeloid Leukemia, Chronic Trial in Berlin, Bremen (DC vaccine)
Recruiting
- Myeloid Leukemia, Chronic
- DC vaccine
-
Berlin, Germany
- +1 more
Aug 3, 2021
Versius Or Laparoscopic Colorectal Cancer and Non-cancer
Recruiting
- Colorectal Disorders
- Laparoscopic Surgeon
- Robotic Arm
-
Milton Keynes, Bucks, United KingdomMilton Keynes University Hospital
Aug 1, 2022
Neuroblastoma Trial in New York (adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH,
Active, not recruiting
- Neuroblastoma
- adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
- oral β-glucan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 11, 2021
Lymphoma Trial in Omaha (keyhole limpet hemocyanin, sargramostim, tumor cell-based vaccine therapy)
Completed
- Lymphoma
- keyhole limpet hemocyanin
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jan 13, 2018
Lymphoma Trial in Stanford, Omaha (keyhole limpet hemocyanin, sargramostim, tumor cell-based vaccine therapy)
Completed
- Lymphoma
- keyhole limpet hemocyanin
- +7 more
-
Stanford, California
- +1 more
Jan 13, 2018
Germ Cell Tumor, Leukemia, Lymphoma Trial in Minneapolis (keyhole limpet hemocyanin, tetanus toxoid)
Terminated
- Germ Cell Tumor
- +3 more
- keyhole limpet hemocyanin
- tetanus toxoid
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 27, 2017
Vaccination With Tetanus and KLH to Assess Immune Responses.
Terminated
- Cancer
- Intracel KLH Vaccine
- +3 more
-
Minneapolis, MinnesotaDivision of Hematology, Oncology, and Transplantation 420 Delawa
Nov 27, 2017
Partial Anomalous Pulmonary Venous Connection Trial in Leeds (Endovascular pulmonary artery flow-limiting covered stent
Not yet recruiting
- Partial Anomalous Pulmonary Venous Connection
- Endovascular pulmonary artery flow-limiting covered stent implantation
-
Leeds, West Yorkshire, United KingdomLeeds Teaching Hospitals NHS Trust
Sep 14, 2023